United Microelectronics Corp vs State Street SPDR S&P Biotech ETF — how do they compare? United Microelectronics Corp trades at $21.15 (market cap $51.00B), while State Street SPDR S&P Biotech ETF trades at $154.43. The key difference: United Microelectronics Corp pays a 2.03% dividend while State Street SPDR S&P Biotech ETF pays none, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, United Microelectronics Corp nearer its low. Which is the better fit depends on your goals.
| UMC | XBI | |
|---|---|---|
Market Cap | $51.00B | — |
Sector | Technology | Broad Market / Factor |
52-Week High | $28.02 | $164.28 |
52-Week Low | $6.58 | $85.16 |
Enterprise Value | $48.57B | — |
Dividend Yield | 2.03% | — |
Signals from Pluang's Aura AI — not financial advice
UMC trades at $21.19, down 0.28% on the day, with a bullish technical signal from oscillators but bearish moving averages. The company reported Q1 2026 EPS of $0.20, beating expectations, and maintains a net income margin of 20.25%. Recent news highlights mass production of silicon photonics ICs and strong June 2026 sales growth of 22.85% year-over-year.
Outlook is supported by earnings beats and specialty technology demand, but risks include valuation above sector peers and competitive pressures. Analysts are mixed with 26.67% buy ratings, suggesting cautious optimism amid solid execution.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Founded in 1980, United Microelectronics is the world's third-largest dedicated chip foundry, with 7% market share in 2021, according to Gartner, after TSMC and GlobalFoundries. UMC's headquarters are in Hsinchu, Taiwan, and it operates 12 fabs in Taiwan, Mainland China, Japan and Singapore, with additional sales offices in Europe, the U.S. and South Korea. UMC features a diverse customer base including Texas Instruments, MediaTek, Qualcomm, Broadcom, Xilinx and Realtek, supplying a wide range of products applied in communications, display, memory, automotive and more. UMC employs about 20,000 people.
Read more on UMC →XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →